Comments for: Study: Cervical cancer vaccine confers long-lasting protection

Study: Cervical cancer vaccine confers long-lasting protection
WASHINGTON – Efforts to develop the world’s first vaccine to prevent cervical cancer took a key step forward Monday with test results suggesting that it can provide long-lasting protection. Four years after getting the vaccine, 94 percent of women were protected from infection with the… Read More
      Read more

      You may also like

      By continuing to use this site, you give your consent to our use of cookies for analytics, personalization and ads. Learn more.